Subchronic Use of the St. Jude Centrifugal Pump as a Mechanical Assist Device in Calves

Jack Curtis,Colette Wagner-Mann,Fred Mann,Todd Demmy,Joseph Walls,James Turk
DOI: https://doi.org/10.1111/j.1525-1594.1996.tb04498.x
Abstract:The purpose of this experiment was to study the effects of the St. Jude Lifestream centrifugal pump on hemodynamic and hematologic parameters and the incidence of postmortem findings in a subchronic ex vivo left ventricular assist animal model. Five calves were implanted with the pump as a left ventricular assist device (left atrial to thoracic aorta bypass) and studied for 96 h of continuous pumping under identical conditions. Heparin (100 IU/kg) was administered only in the initial saline pump prime. Throughout the protocol, mean arterial and central venous pressures averaged 102.1 ± 4.6 and 3.4 ± 2.2 mm Hg, respectively. Pump flow was 47.8 ± 8.4 ml/kg/min at a mean pump speed of 1,676.3 ± 106.1 rpm. No clinical abnormalities or mechanical malfunctions attributable to the pump were detected during the 96 h of continuous pumping for each calf. Mean plasma-free hemoglobin after 96 h was 3.9 ± 3.7 u, mol/L (p = 0.337 compared to baseline). At post mortem, renal infarctions were detected in 1 calf. No other pump-associated lesions were detected in any of the other calves. We have concluded that the St. Jude Lifestream centrifugal pump functions reliably during 96 h of continuous left heart bypass in a calf model.
What problem does this paper attempt to address?